Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Mar 15;15(3):469.
doi: 10.3390/life15030469.

Interleukin 8 Molecular Interplay in Allergic Rhinitis and Chronic Rhinosinusitis with Nasal Polyps: A Scoping Review

Affiliations
Review

Interleukin 8 Molecular Interplay in Allergic Rhinitis and Chronic Rhinosinusitis with Nasal Polyps: A Scoping Review

Romica Cergan et al. Life (Basel). .

Abstract

The present scoping review underlines the molecular interplay between allergic rhinitis (AR), chronic rhinosinusitis with nasal polyps (CRSwNP), and interleukin-8 (IL-8). A query of PubMed database resulted in the inclusion of 34 articles in the final analysis of this scoping review. IL-8 is one interconnecting immune mediator in the physiopathology of AR and CRS. An influx of cytokines, such as interleukin (IL)-4 and IL-13, occurs from mast cells, four to six hours after the initial response signifying the development of the late-phase response allowing the entrance of eosinophils, basophils, and T-lymphocytes at the level of nasal mucosa. Chronic rhinosinusitis (CRS) is a chronic inflammatory disease that occurs in the mucosa of the nasal cavity and sinuses with two external phenotypes, but with molecular mechanisms that overlap with allergic rhinitis. Interleukin 8 induces neutrophil chemokinetic movement providing a chemotactic or directional cue. Clinical and fundamental studies established an implication of IL-8 in the disease mechanism of allergic rhinitis and CRSwNP. Moreover, there is still missing a randomized, large-cohort study with three patients groups (normal control, AR, CRSwNP) that analyzes the impact of IL-8 simultaneously. Future possible developments could focus on IL-8 as possible target for biologic treatments.

Keywords: allergic rhinitis; interleukin; sinusitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
PRISMA diagram of the current scoping review about the importance of IL-8 in AR and CRSwNP.
Figure 2
Figure 2
Chart showing the distribution of the included articles after the publishing year.
Figure 3
Figure 3
Timeline showing key steps in the chronology of research regarding IL-8 and AR [11,12,13,14,15,16,17,19,20,21,22,23,24,25,26,27].
Figure 4
Figure 4
Timeline showing key steps in the chronology of research regarding IL-8 and CRSwNP [29,30,31,32,33,34,35,36,37].

References

    1. Liu J., Wang M., Tian X., Wu S., Peng H., Zhu Y., Liu Y. New insights into allergic rhinitis treatment: MSC nanovesicles targeting dendritic cells. J. Nanobiotechnol. 2024;22:575. doi: 10.1186/s12951-024-02748-2. - DOI - PMC - PubMed
    1. Huber P., Gröger M., Stihl C., Frankenberger H., Bertlich M., Haubner F., Gellrich D. Diagnostics of allergic rhinitis under dupilumab therapy. Eur. Arch. Otorhinolaryngol. 2024;281:4183–4190. doi: 10.1007/s00405-024-08700-2. - DOI - PMC - PubMed
    1. Deng X.H., Huang L.X., Sun Q., Li C.G., Xie Y.C., Liu X.Q., Fu Q.L. Increased circulating LOX-1+ neutrophils activate T cells and demonstrate a pro-inflammatory role in allergic rhinitis. Heliyon. 2024;10:e36218. doi: 10.1016/j.heliyon.2024.e36218. - DOI - PMC - PubMed
    1. Liu J.Y., Qiao Y.L., Jiao W.E., Tao Z.Z., Xu S., Chen S.M. Changes in Circulating CD44+CD62L- Treg Subsets and CD44-CD62L+ Treg Subsets Reflect the Clinical Status of Patients with Allergic Rhinitis. Int. Arch. Allergy Immunol. 2024;186:120–132. doi: 10.1159/000540536. - DOI - PubMed
    1. Sio Y.Y., Du K., Lam T.Y.W., Say Y.H., Reginald K., Chew F.T. Functional Polymorphisms Regulate FOXO1 Transcript Expression and Contribute to the Risk and Symptom Severity of HDM-Induced Allergic Rhinitis. Int. Arch. Allergy Immunol. 2024;186:1–11. doi: 10.1159/000540686. - DOI - PMC - PubMed

LinkOut - more resources